The increased attention on methamphetamine as a substance of abuse has proceeded without concurrent innovations deploying its utility as a valid pharmaceutical. Its medicinal properties have not been considered as a basis to understand and correct pathological using patterns. There is a dearth of medical and treatment programs that develop stimulant science for purposeful applications, despite well-known medicinal properties of methamphetamine. The neglected areas of practice are addressed by way of a theoretical development of an approach guided by existing literature. Methamphetamine science has a 100-year journal literature that includes the findings of recent experimental trials, where the pharmacy was found to strengthen the metacognition of agency under known dose structure. Proposed treatment principles are developed, premising the urgency to test those with formulations as the basis of further clinical trials. A defined treatment framework is also presented for deploying metacognition during relapse prevention. Treatment targets for sexual trauma recovery are formulated, because of the pharmacy’s potential to support the sexual neuropsychology of the parasympathetic nervous system during recovery. Materials are summarised in five new treatment principles that are developed within combination metacognitive-CBT based frameworks. Psychopharmacological treatment concepts are summarised within the fortified cognition hypothesis. Proposed Sexual Stress Immunisation Protocols (SSIPs), guided by the principles of fortified cognition, preface new trauma and relapse prevention concepts, in their basis for clinical testing.
Published Date: 2019-05-11; Received Date: 2019-01-16